Cargando...
Enoxaparin dose reduction for thrombocytopenia in patients with cancer: a quality assessment study
The development of thrombocytopenia in the setting of therapeutic anticoagulation for venous thromboembolic disease (VTE) is common in cancer patients, but guidelines for management are based on limited past data and have not been validated. In 2011, Memorial Sloan Kettering Cancer Center (MSKCC) im...
Gardado en:
| Publicado en: | J Thromb Thrombolysis |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer US
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5375964/ https://ncbi.nlm.nih.gov/pubmed/28205078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-017-1478-0 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|